Between the Fed’s aggressive policy tightening to rein in inflation and deteriorating economic data, volatility has become a seemingly ever-present facet of the …
VistaGen Therapeutics (VTGN) is a biopharmaceutical company developing medicines targeting several nervous system disorders. On June 29, the company released its Fiscal 2021 …
Investors love biotech stocks for the lottery ticket-like returns they can offer if a company strikes medical gold or wins the regulator’s blessing. …
Shares of drug maker Vistagen (NASDAQ:VTGN) skyrocketed nearly 60% on Friday after the stock received a positive mention in an Oppenheimer analyst report, …
It’s a very rewarding trading day for investors in Vistagen Therapeutics Inc (NASDAQ:VTGN) with shares rising over 140%, making the stock Wall Street’s …
